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ABSTRACT: We used cysteine-scanning and spin-labeling methods to prepare singly spin labeled recombinant
peptides for electron paramagnetic resonance studies of the partial domain regions at the tetramerization
site (N-terminal end of R and C-terminal end of β) of erythroid spectrin. The values of the inverse line
width parameter (∆H0-1) from a family of SpRI-1-368∆ peptides scanning residues 21-30 exhibited a
periodicity of ∼3.5-4. We used molecular dynamics calculations to show that the asymmetric mobility
of this helix is not necessarily due to tertiary contacts, but is likely due to intrinsic properties of helix C′,
a helix with a heptad pattern sequence. The residues with low ∆H0-1 values (residues at positions 21, 25,
and 28/29) were those on the hydrophobic side of this amphipathic helix. Native gel electrophoresis results
showed that these residues were functionally important and are involved in the tetramerization process.
Thus, EPR results readily identified functionally important residues in the R spectrin partial domain region.
Mutations at these positions may lead to clinical symptoms. Similarly, the ∆H0-1 values from a family of
spin-labeled SpβI-1898-2083∆ peptides also exhibited a periodicity of ∼3.5-4, indicating a helical
conformation in the two scanned regions (residues 2008-2018 and residues 2060-2070). However, the
region consisting of residues 2071-2076 was in a disordered conformation. Both helical regions include
a hydrophilic side with high ∆H0-1 values and a hydrophobic side with low ∆H0-1 values, demonstrating
the amphipathic nature of the helical regions. Residues 2008, 2011, 2014, and 2018 in the first scanned
region and residues 2061, 2065, and 2068 in the second scanned region were on the hydrophobic side.
These residues were critical in Rβ spectrin association at the tetramerization site. Mutations at some of
these positions have been reported to be detrimental in clinical studies.

Spectrin, a member of the spectrin superfamily and a major
protein in the membrane (cyto)skeleton, is ubiquitous among
vertebrate tissues, as well as in simple metazoans, implying
that spectrin plays a fundamental role in cells (1-9). After
first being identified in erythrocytes (10), many distinct
spectrin isoforms have since been discovered.
Several functions of spectrin involve its interactions with
other components [spectrin-actin interaction, spectrinmembrane interaction, spectrin-ion channel interaction, etc.
(3)], yet some of the most fundamental functions of spectrin
involve spectrin “self-association” {two heterodimers (Rβ)
associating to form a functional tetramer [(Rβ)2] (11)}.
†
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Several hereditary hemolytic anemia diseases involve singleamino acid mutations in spectrin that destabilize its tetramers,
resulting in low levels of spectrin tetramers and high levels
of dimers (4, 12, 13). Thus, the tetramerization site is an
important functional site for most spectrin isoforms. The best
studied spectrin tetramer is that from human erythrocyte
[(RIβI)2].
The tetramerization site consists of the N-terminal region
of the R subunit (RN)1 and the C-terminal region of the β
subunit (βC). Tetramer formation involves a pair of RNβC (R1N-β2C and R2N-β1C) associations to give an
R1β2R2β1 tetramer (14-17). At the other end of the spectrin
molecule, the C-terminal region of the R subunit and the
N-terminal region of the β subunit associate with higher
affinity, and these regions are termed the nucleation site. We
assume that these two major assembly sites (the dimerization/
nucleation site and the tetramerization site) are independent
2
Abbreviations: RN, N-terminal region of the R subunit; βC,
C-terminal region of the β subunit; CD, circular dichroism; DTT,
dithiothreitol; EPR, electron paramagnetic resonance; ∆H0-1, inverse
line width parameter; helix C′, R partial domain; Ms, scaled mobility
parameter; MTSSL, (1-oxy-2,2,5,5-tetramethyl-3-pyrrolinyl-3-methyl)methanethiosulfonate spin-label; PBS, 5 mM phosphate buffer (pH 7.4)
containing 150 mM NaCl; SpRI, erythroid R spectrin; SpβI, erythroid
β spectrin; TFE, 2,2,2-trifluoroethanol.
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sites (18, 19). On the basis of this premise, we use
recombinant peptides of spectrin fragments as model systems
for specific regions of spectrin to study the local structures
at the tetramerization site of spectrin.
On the basis of sequence homology, it has long been
suggested that both RN and βC regions of erythroid spectrin
consist of partial domains, with a single helix for the RN
region and two helices for the βC region (15, 20). Currently,
only the structure of the N-terminal region of erythroid R
spectrin (SpRI) has been determined experimentally by NMR
methods. The solution NMR structures of a recombinant
peptide that consists of the first 156 residues of SpRI show
that the first 20 residues preceding and the seven residues
following the first helix (helix C′) are in a disordered
conformation (21). The three subsequent helices (helices A1C1) form a triple-helical bundle structural domain that is
similar, but not identical, to previously published structures
for spectrin from Drosophila (22) and chicken brain (23).
However, no experimental structural information is available
for β spectrin at the tetramerization site.
In this study, we use cysteine-scanning and spin-labeling
methods to prepare singly labeled recombinant, erythroid R
and β spectrin peptides for electron paramagnetic resonance
(EPR) studies. Site-directed cysteine-scanning spin-label EPR
studies have become a powerful tool for monitoring the
structure and dynamics of protein systems that are not easily
studied by either NMR or X-ray methods (24, 25).
MATERIALS AND METHODS
Spectrin Recombinant Peptides. The SpRI-1-368, SpRI1-156, and SpβI-1898-2083 peptides were prepared as
described previously (19, 26). SpRI-1-368 is a peptide with
the first 368 amino acid residues of SpRI, consisting of the
partial domain and the first three structural domains; SpRI1-156 is a peptide with the first 156 amino acid residues,
consisting of the partial domain and the first structural
domain (27). SpβI-1898-2083 is a peptide with the sequence
of amino acid residues 1898-2083, a region being considered to consist of the last structural domain followed by the
partial domain in SpβI (19). A cysteine-less peptide derived
from SpβI-1898-2083 with cysteine residues at positions
1962 and 2012 replaced with alanine residues (SpβI-18982083-cysteine-less) was prepared first. With this peptide, 11
single-cysteine peptides scanning positions 2008-2018
(βL2008C, βL2009C, βE2010C, βV2011C, βC2012,
βQ2013C, βF2014C, βS2015C, βR2016C, βD2017C, and
βA2018C) and 17 single-cysteine peptides scanning positions
2060-2076 (βS2060C, βW2061C, βA2062C, βE2063C,
βR2064C, βF2065C, βA2066C, βA2067C, βL2068C,
βE2069C, βK2070C, βP2071C, βT2072C, βT2073C,
βL2074C, βE2075C, and βL2076C) were then prepared,
using the pGEX-2T vector containing the cDNA for SpβI1898-2083-cysteine-less as the template, and primers designed to introduce a cysteine at a specific position for each
peptide. On the basis of the sequence homology alignment,
we have proposed a working model for the structure of the
two helices (helix A′ and helix B′) in the SpβI partial domain
(19). In this working model, helix A′ begins at residue 2008
and ends at residue 2037 while helix B′ begins at residue
2044 and ends at residue 2072. We have also shown that
recombinant peptides that terminate at positions 2072 and
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2073 associate with an R peptide, whereas the peptides that
terminate at a position prior to residue 2072 do not associate
with the R peptide (27). Thus, we scanned the region that
presumably consists of the beginning of helix A′ (residues
2008-2018) and a region that consists of the end of helix
B′ (residues 2060-2076). These 28 peptides were collectively termed β∆ peptides.
Each DNA fragment inserted into the pGEX-2T vector
was sequenced, and only those that were confirmed to have
incorporated the cysteine residue as well as the positions of
the start and stop codons were used for protein expression.
Similarly, a SpRI-1-368-cysteine-less peptide with the
three native cysteine residues sequentially replaced with
alanine residues (27) and 10 single-cysteine peptides scanning positions 21-30 in SpRI-1-368 (RA21C, RE22C,
RE23C, RI24C, RQ25C, RE26C, RR27C, RR28C, RQ29C,
and RE30C) were prepared. These peptides were collectively
termed as R∆ peptides.
All peptides were purified by thrombin cleavage from the
GST fusion protein following standard laboratory methods
(28). As part of the thrombin recognition sequence, residues
G and S remained as the first two residues in all peptides
after thrombin cleavage. Peptide identity and purity were
checked by polyacrylamide gel electrophoresis and mass
spectrometry using electrospray ionization techniques. Protein
concentrations were determined with absorbance values at
280 nm, using extinction coefficient values determined from
the primary sequence (31 010 cm-1 M-1 for all peptides in
the SpβI-1898-2083 family except for βW2061C, for which
a value of 25 320 cm-1 M-1 was used; 16 500 cm-1 M-1
for SpRI-1-156; and 50 070 cm-1 M-1 for peptides in the
SpRI-1-368 family). Each peptide was analyzed by circular
dichroism (CD) methods (19) to ensure its folding integrity.
NatiVe Gel Electrophoresis. The association of spin-labeled
peptides of the SpβI-1898-2083 family with SpRI-1-156
and of the SpRI-1-368 family with SpβI-1898-2083 were
monitored by native gel electrophoresis (19). The R (10 µM)
and β (20 µM) peptides were added in a 1:2 molar ratio
(total of 4 µg) and incubated in 5 mM phosphate buffer (pH
7.4) containing 150 mM NaCl (PBS7.4) at 4 °C for ∼16 h
before electrophoresis was carried out with a 6% native
polyacrylamide gel (19).
Spin Labeling. The single-cysteine R or β peptides were
mixed with dithiothreitol (DTT) at 37 °C for 1 h to reduce
the cysteine residue, followed by size-exclusion column
chromatography to remove DTT and incubation with a 5-fold
molar excess of spin label (1-oxy-2,2,5,5-tetramethyl-3pyrrolinyl-3-methyl)methanethiosulfonate (MTSSL) (Toronto
Research Chemicals, Toronto, ON) for 3 h at room temperature in the dark. To determine background labeling, cysteine-less samples (SpβI-1898-2083∆ and SpRI-1-368∆)
were also processed, in parallel. Excess spin-labels were
removed with size-exclusion column chromatography. The
concentrations of spin-labels bound to each peptide were
determined from spectra of labeled samples without sucrose
additions. The peptide concentrations were determined from
the absorbance values at 280 nm, as indicated above. The
concentration ratio of the spin-label to the peptide was
calculated for each peptide. Generally, ∼10-15% background labeling was observed in cysteine-less samples, and
thus, this was subtracted to give the number of spin-labels
per protein molecule.
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FIGURE 1: Native polyacrylamide gel (6%) electrophoresis to determine the association of spin-labeled R peptides with SpβI-1898-2083
(A) and spin-labeled β peptides with SpRI-1-156 (B and C). Each sample contained ∼4 µg of protein. The gels were run at 20 °C in 40
mM Tris, 20 mM sodium acetate, and 2 mM EDTA at pH 7.4. (A) For lanes 1-10, the odd-numbered lanes were loaded with the following
R peptides sequentially: RA21C (lane 1), RE22C (lane 3), RE23C (lane 5), RI24C (lane 7), and RQ25C (lane 9). The Rf values of the band
in these lanes were ∼0.51. The even-numbered lanes were loaded with corresponding R peptides (10 µM) with SpβI-1898-2083 (20 µM).
For example, RA21C and SpβI-1898-2083 were in lane 2. The appearance of a band with Rf values of ∼0.31, the Rf value for SpβI1898-2083, and the disappearance of the band with Rf values of ∼0.51 in these even-numbered lanes demonstrated the association of the
limiting R peptide with excess SpβI-1898-2083. Thus, the results show that RA21C (lane 2), RE22C (lane 4), RE23C (lane 6), and RQ25C
(lane 10) associated with SpβI-1898-2083, but RI24C (lane 8) did not. The SpβI-1898-2083 sample was loaded into lanes 11 and 22. For
lanes 12-21, even-numbered lanes were loaded with R peptides: RE26C (lane 12), RR27C (lane 14), RR28C (lane 16), RQ29C (lane 18),
and RE30C (lane 20). The odd-numbered lanes were loaded with corresponding R peptides with SpβI-1898-2083. For example, RE26C
and SpβI-1898-2083 were in lane 13. The results show that peptides RE26C (lane 13), RR27C (lane 15), RQ29C (lane 19), and RE30C
(lane 21) associated with SpβI-1898-2083, but RR28C (lane 17) did not. (B) Association of SpRI-1-156 with single-cysteine β peptides
scanning residues 2008-2018. Lane 1 was loaded with SpRI-1-156, lane 2 with cysteine-less SpβI-1898-2083, and lane 3 with their
mixtures. Lanes 4-14 were mixtures of SpRI-1-156 (10 µM) with an individual single cysteine β peptide (20 µM): βL2008C (lane 4),
βL2009C (lane 5), βE2010C (lane 6), βV2011C (lane 7), βC2012 (lane 8), βQ2013C (lane 9), βF2014C (lane 10), βS2015C (lane 11),
βR2016C (lane 12), βD2017C (lane 13), and βA2018C (lane 14). These data suggest that all β peptides associated with SpRI-1-156
except βV2011C, βF2014C, and βA2018C. (C) Association of SpRI-1-156 with single-cysteine β peptides scanning residues 2060-2076.
Lane 1 was loaded with SpRI-1-156 and lane 2 with cysteine-less SpβI-1898-2083. Lanes 3-19 were mixtures of SpRI-1-156 (10 µM)
with individual β peptides (20 µM): βS2060C (lane 3), βW2061C (lane 4), βA2062C (lane 5), βE2063C (lane 6), βR2064C (lane 7),
βF2065C (lane 8), βA2066C (lane 9), βA2067C (lane 10), βL2068C (lane 11), βE2069C (lane 12), β K2070C (lane 13), βP2071C (lane
14), βT2072C (lane 15), βT2073C (lane 16), βL2074C (lane 17), βE2075C (lane 18), and βL2076C (lane 19). These results show that all
β peptides, except βW2061C, βF2065C, βL2068C, βE2069C, and βP2071C, associated with SpRI-1-156.

EPR Studies. The spin-labeled EPR samples (∼100 µM)
were in PBS7.4 in the presence or absence of 30% sucrose.
The addition of sucrose reduces the contribution of the
overall motion of the protein to the EPR spectral line shape
(29). Some samples of R peptides also included 60% 2,2,2trifluoroethanol (TFE). Spectra were acquired at 21 °C with
a Varian E109 spectrometer equipped with a TM 102 cavity
at 9.41 GHz (X-band). After the removal of background
signals (see Spin Labeling), the spectra were normalized to
represent the same number of spins, as determined by the
double-integration method. The inverse values of the peakto-peak line width of the central resonance signal (∆H-1)
were obtained from EPR spectra of samples in 30% sucrose.
Each ∆H-1 value was scaled according to the maximum and
minimum ∆H-1 values in the family of peptides to give a
scaled mobility parameter Ms, a parameter that reflects
changes in both the ordering and mobility of the nitroxide
motion and was easier to measure even in spectra with poor
signal-to-noise ratios (25), as in β peptides which exhibited
lower solubilities than R peptides.
Molecular Dynamics Calculations. The NMR structure for
the region consisting of residues 21-45 (helix C′) was used
as the starting structure for energy minimization until the
root-mean-square deviation (rmsd) was less than 0.1 kcal
mol-1 Å-1. The resulting single helix was then surrounded

with water molecules (a total of 3714), which extended 10
Å from the helix surface, in a periodic box (51.7 Å × 58.1
Å × 50.3 Å) with a TIP3P potential (30). The energy
minimization and molecular dynamics (MD) simulations
were carried out with the SANDER module in AMBER7.0
(31) using the PARM99 force field (32). The particle mesh
Ewald (PME) method (33) was then used for electrostatics,
and SHAKE (34) was used for restricting motion of all
covalent bonds involving hydrogen. MD simulations were
carried out at 300 K and 1 atm with a time step of 2.0 fs
and the nonbonded cutoff at 12.0 Å. The temperature during
MD simulation was maintained by the Berendsen coupling
algorithm (35). The total MD simulation time was 1000 ps.
After equilibration for 200 ps, a total of 80 snapshots were
collected every 10 ps for root-mean-square deviation calculations. The CARNAL module in AMBER7.0 (31) was used
for rmsd calculation. First, an average structure was constructed by averaging the coordinates of the 80 snapshots.
Then, each snapshot was overlapped with the average
structure to calculate the rmsd value of each side chain.
RESULTS
Peptide Analysis. Densitometric analysis of SDS-PAGE
gels indicated that all R and β peptides were at least 95%
pure. Molecular masses from electrospray ionization mass

Spectrin Tetramerization
spectrometry were within 0.1% of the theoretical values. CD
analysis of spin-labeled R and β peptides showed helicity
contents similar to those of parent peptides (19), ranging from
60 to 70%, with R peptides ∼10% higher than those for β
peptides. βP2071C exhibited a slightly lower helical content
(∼45%). Spin labeling did not change the helicity values of
the peptides. Addition of 30% sucrose to samples caused
slight increases in their helicity values.
The spin-label to peptide molar ratio was found to be
between 0.5 and 1.0 for all R and β peptides, with most
around 1.
Association of Spin-Labeled R Peptides with the CTerminal Region of β Spectrin. The association of SpRI-1368 with SpβI-1898-2083 in the micromolar concentration
range (1:2 molar ratio of R and β) was easily visualized on
a native gel due to the disappearance of the band corresponding to SpRI-1-368 (Rf ) 0.51) and the appearance of
a band corresponding to SpβI-1898-2083 and the Rβ
complex (Rf ) 0.31-0.32) (19). All R peptides (Figure 1A,
lanes 2, 4, 6, 10, 13, 15, 19, and 21), except RI24C (lane 8)
and RR28C (lane 17), were found to associate with SpβI1898-2083.
Association of Spin-Labeled β Peptides with the NTerminal Region of R Spectrin. The SpRI-1-156 peptide,
which is smaller than SpRI-1-368 but has an Rf value similar
to that of SpRI-1-368 (19), was used as a model peptide to
determine if the β peptides associated with the N-terminal
region of R spectrin. Among the 28 single-cysteine β
peptides, 20 β peptides (Figure 1B, lanes 4-6, 8, 9, and
11-13, and Figure 1C, lanes 3, 5-7, 9, 10, 13, and 15-19)
associate with SpRI-1-156 in the micromolar concentration
range. The eight remaining peptides [βV2011C (Figure 1B,
lane 7), βF2014C (Figure 1B, lane 10), βA2018C (Figure
1B, lane 14), βW2061C (Figure 1C, lane 4), βF2065C
(Figure 1C, lane 8), βL2068C (Figure 1C, lane 11), βE2069C
(Figure 1C, lane 12), and βP2071C (Figure 1C, lane 14)]
did not associate with SpRI-1-156 at micromolar concentrations.
EPR Measurements of the R Peptides. EPR spectra of the
10 spin-labeled R peptides, scanning positions 21-30, in
PBS7.4 buffer show line shape variations in these spectra,
and the variations became systematic for spectra of samples
with 30% sucrose (Figure 2). For the spectra of samples in
sucrose, the first and fifth positions exhibited very similar
line shapes. For example, spectra with spin-labels at positions
21 (RA21C), 25 (RQ25C), and 29 (RQ29C) show distinctive
multicomponent features with highly anisotropic motions for
the nitroxide moiety, whereas those at positions 22 (RE22C),
26 (RE26C), and 30 (RE30C) reflect more mobile motions,
similar to those of nitroxide labels with unrestricted motions
on helix surfaces (29). Spectra with spin-labels at positions
23 (RE23C) and 27 (RR27C) are similar, representing
nitroxide labels with greater flexibility, whereas those at
positions 24 (RI24C) and 28 (RR28C) show more restricted
motions.
A more quantitative examination of the ∆H0-1 values in
this series (Figure 3A) indicates that the maximum value
was 0.38 (residues 22 and 26), and the minimum value was
0.25 (residue 28). Under similar sample and experimental
conditions, values of ∆H0-1 below 0.32 are often used to
indicate relatively restricted motion, while values of ∆H0-1
between 0.32 and 0.38 are indicative of less restricted
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FIGURE 2: EPR spectra of spin-labeled R peptides scanning residues
21-30 in PBS7.4 buffer without (left column) and with 30%
sucrose (right column) at 20 °C. The spectra were normalized to
represent the same number of spins in each spectrum, as determined
by double integration. The contribution of the background spinlabel (see Materials and Methods) was subtracted from each
spectrum.

motions such as those for residues on helix surfaces (29,
36). The ∆H0-1 values show a periodicity of 3.5-4 as a
function of the residue position, suggesting a helical conformation in this region.
For samples in 60% TFE [TFE is a solvent known to affect
hydrogen bonding and solvent structure (see refs 37 and 38)
and thus hydrophobicity], the range of line shape variation
became smaller, noticeably around positions 27-30 (Figure
3A). There also appeared to be a phase shift in the periodic
pattern. The ∆H0-1 values were shifted to higher values in
60% TFE than in 30% sucrose since the viscosity values of
the samples in 60% TFE were much lower than those in
30% sucrose. The viscosity of TFE (100%) is ∼1.78 cP (38,
39), whereas the viscosity of 30% sucrose is ∼3.19 cP (40).
The rmsd Values of the R Partial Domain Side Chains.
The rmsd values from molecular dynamics calculations show
various side chain flexibilities (Figure 3B). The values ranged
from 0.29 to 0.84 Å, with residues 24 and 28 being less
flexible and residues 22, 26, and 29 being more flexible.
The average rmsd value of these 10 side chains was 0.60 Å.
The rmsd variations (or side chain flexibilities) also exhibit
a periodic pattern (Figure 3B), similar to that observed in
EPR data (either ∆H0-1, Figure 3A, or Ms, Figure 3B,
values). Thus, it appears that, even without tertiary contacts,
the side chains on the hydrophobic side of the lone helix C′
are less flexible than those on the hydrophilic side of the
helix.
EPR Studies of the β Peptides. The EPR spectra of the β
peptides with spin-labels at positions 2008-2018 and 20602076 again exhibited a similar periodic pattern in either
∆H0-1 (Figure 5A,C) or Ms (Figure 5B,D) values as a
function of residue position. Spectra of the peptide with a
spin-label at position 2008 exhibited highly anisotropic
motion. Spectra at positions 2009-2018 as well as 20602070 were similar to those of R peptides scanning the
beginning of helix C′ and similar to typical two-component
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FIGURE 3: (A) Plot of the values of the inverse of the EPR central
line width (∆H-1) vs residue number of R (SpRI-1-368) peptides
in 30% sucrose (9) to show the periodic variation of ∆H-1 as a
function of residue position. The dotted line is a sine wave with a
periodicity of 4. Values of ∆H-1 of <0.32 are indicative of
relatively restricted motion, whereas values of ∆H-1 of >0.34 are
indicative of more mobile motions. A typical standard deviation
error bar (n ) 3) is shown at position 30. Also shown are the values
of samples in the presence of 60% TFE (2). (B) rmsd values (b)
of residues 21-30 of RI spectrin obtained from energy minimization
and molecular dynamics calculations in the presence of water
molecules. The starting structure was obtained from NMR studies.
The values of the scaled mobility parameter Ms (0), obtained from
∆H-1 values, followed similar periodic variations as a function of
residue position.

spectra of spin-labeled side chains attached to a helical
backbone (29). The ∆H0-1/Ms values (Figure 5) indicated
that the flexibility of sequential residues oscillated between
being more flexible to less flexible for spin-labels at positions
2008-2018 as well as positions 2060-2070. The periodicity
of ∼3.5-4 corresponds with the periodicity of a helix.
However, this periodicity pattern was not found for residues
2071-2076. The EPR spectra of these six positions were
similar to those of a spin-labeled side chain with high
flexibility, such as those in a loop or disordered conformation
(29).
DISCUSSION
It has long been suggested that both R and β subunits of
erythroid spectrin consist mostly of triple-helical bundle
structural domains, and each with a partial domain at the
tetramerization site (20). However, since these subunits are
fairly large (consisting of more than 2000 amino acid
residues) and flexible, detailed experimental information
about the structure of intact spectrin is still not available.
We, as well as many others, have used recombinant peptides
to model functionally important segments of spectrin and
determined structural and functional properties of these
spectrin peptides (19, 21, 26, 27).
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FIGURE 4: EPR spectra of spin-labeled β (SpβI-1898-2083)
peptides scanning residues 2008-2018 and 2060-2076 in PBS7.4
buffer containing 30% sucrose at 20 °C. The spectra were
normalized to represent the same number of spins in each spectrum,
as determined by double integration. The contribution of the
background spin-label was subtracted from each spectrum.

Structure of the R Spectrin Partial Domain. Our NMR
studies of SpRI-1-156 showed that the R spectrin partial
domain consists of a single helix (helix C′) and set the
boundary of this helix as being from residue 21 to 45 (21).
The first 20 residues in R spectrin exhibit a disordered
conformation. Following residue 45 is a seven-residue
(residues 46-52) disordered junction region. The first helix
(helix A1) of the first structural domain (residues 52-156)
starts at position 53.
The sequence of helix C′ (residues 21-45), as well as the
sequences of other helical regions in the structural domain,
exhibits a seven-residue (heptad) periodicity. The predicted
structure of a helix with a heptad pattern is a curved (coiled)
helix, with the larger curvature side as the hydrophilic face
and the smaller curvature side as the hydrophobic face of
the helix (41, 42), as seen in the coiled coils of the triplehelical domain region (21, 22). However, because of resolution/sensitivity limitations in high-resolution NMR studies,
the observed structures of helix C′ are presented as a
symmetric (straight) helix, with no distinction between the
hydrophilic and hydrophobic faces of the helix detected (21).
The cysteine-scanning spin-label EPR studies of the region
consisting of residues 21-30 of SpRI-1-368 showed that
the ∆H0-1 values of the scanned residues exhibited a
periodicity of 3.5-4, consistent with the helical nature
predicted from sequence and observed by NMR measurements. The ∆H0-1 values readily show the asymmetric nature
of the helix. This side chain asymmetry in flexibility could
potentially arise either from the hydrophobic moment of the
helix (43, 44) or due to the side chains in one side of the
helix having tertiary contacts with other parts of the molecule.
Since the junction region (residues 46-52) is flexible,
helix C′ may assume many orientations with respect to the
triple-helical structural domain. It is physically possible to
have many structures, from a structure with a lone helix
extending out from the triple-helical bundle to a structure
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FIGURE 5: Plot of the values of ∆H-1 and Ms vs residue number of β (SpβI-1898-2083) peptides scanning residues 2008-2018 (A and
B) and residues 2060-2076 (C and D) in PBS7.4 containing 30% sucrose, showing a periodic variation of ∆H-1/Ms values as a function
of residue position. The dotted lines are sine waves with a periodicity of 3.5. Typical standard deviation error bars of ∆H-1 are shown at
positions 2018, 2069, and 2076 (n ) 3).

with a four-helix bundle, and variations between them (21).
We replaced residue 154 with cysteine, labeled with a spinlabel, and found that several NMR resonances from the
N-terminal region of helix C′ retained their intensities and
were not broadened by the paramagnetic center of the spinlabel. These NMR results unambiguously show that helix
C′ does not bundle with the structural domain to form a fourhelix bundle, and is a lone helix on the NMR time scale
(milliseconds to seconds). Our CD data also show that helix
C′ is a lone helix (19).
The MD calculations show that, in the presence of water
molecules, the side chain flexibility of residues 21-30 in
this lone helix C′ varies with a periodicity similar to that
detected by EPR. In general, the parameter ∆H0-1, or Ms,
obtained in spin-label EPR studies, is often called a measure
of side chain mobility (24, 25, 29). However, it is also stated
that Ms reflects changes in both order (S) and motion (τe)
(25). Thus, helix C′ is a lone helix, with hydrophobic and
hydrophilic faces. The side chains on the hydrophobic face
are more ordered and less flexible, whereas the side chains
on the hydrophilic side are less ordered and more flexible.
These side chain properties cannot be detected by NMR
methods used to determine structures, but are detected by
spin-label EPR. Thus, the asymmetric nature of helix C′ is
easily revealed by ∆H0-1 values, with smaller ∆H0-1 values
for the residues on the hydrophobic face of the helix and
larger ∆H0-1 values for the residues on the hydrophilic face
of the helix. These results are in good agreement with the
heptad assignments, with residues 21, 24, and 28 assigned
to “a” and “d” positions (19).
The addition of TFE promotes helical formation [increases
the helicity of our peptides by 20-30% (19)], and as we
mentioned before, TFE is a solvent known to affect hydrogen

bonding and solvent structure and thus can affect the
hydrophobic face of helix C′ (37, 38). It is interesting to
note that the variations in ∆H0-1 values decreased in the
presence of TFE to an extent that the periodicity pattern was
much less prominent than that without TFE, suggesting that
helix C′ is more symmetric in TFE solution.
The native gel data show that when the residue at position
24 or 28 was replaced with spin-labeled cysteine, the peptide
would not associate with β peptide at micromolar concentrations. Thus, the simple ∆H0-1 versus residue position plot
from cysteine-scanning EPR data identified the hydrophobic
and hydrophilic faces of this amphipathic helix C′, and
revealed residues that are functionally important. The
residues with small ∆H0-1 values, such as residues 21, 25,
28, and 29, are on the hydrophobic face of the helix and
therefore are likely to be critical in tetramerization. Mutations
at some of these sites are known to be deleterious. Mutations
I24S [Spectrin Lograno (45)] and R28X [Spectrin Corbeil,
R28H, for example (46)] have been identified clinically (47).
Residue R28 is known to be a “hot spot” in spectrin (48)
and may be uniquely involved in the tetramerization process.
Our NMR studies of R28S in SpRI-1-156 suggested that
the mutated helix C′ may transiently, on the NMR time scale,
associate with helix A1 and helix C1 (the AC face of the
following structural domain) (49). The R28S substitution
deletes the cationic surface side chain, and thus may permit
the transient association, giving rise to exchange effects in
the NMR spectrum.
EPR data suggest that mutations at residues 21, 25, and
29 may also lead to clinical symptoms.
Structure of the β-Spectrin Partial Domain. Structural
information about the β spectrin partial domain is mostly
derived from sequence predictions at this time, suggesting
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two helical segments, similar to the first two helices (helix
A and helix B) in a spectrin structural domain. Our CD
studies suggest that the two helices are not associated (19).
The βC partial domain consists of more than 60 amino
acid residues, making a peptide similar to SpRI-1-156,
consisting of the partial domain plus one full structural
domain, making it too large and difficult for high-resolution
NMR studies. A smaller peptide, consisting of the sequence
of only the β partial domain, was insoluble in buffers (L.
W.-M. Fung, unpublished observation) and thus difficult to
assess in structural studies. Crystal growth of intact spectrin
has not been successful for X-ray diffraction studies. Thus,
cysteine-scanning spin-label EPR studies appear to be ideal
for secondary structural information of the partial domain
at the C-terminal end of βI spectrin that are critical in
tetramerization.
The ∆H0-1/Ms values of the region consisting of residues
2008-2018 exhibited a periodicity of 3.5-4, again suggesting a helical backbone for this region (for simplicity, we
refer to this region as helix A′). The ∆H0-1 values at positions
2008, 2011, 2014, and 2018 were relatively low, thus
indicating that these were the residues on the hydrophobic
side of helix A′. It is not clear at this time why the ∆H0-1
values at position 2008 were particularly low. It is reassuring
to know that residues at positions 2011, 2014, and 2018 are
assigned to “a” and “d” heptad positions (19). Interestingly,
native gel results showed that, when each of the residues at
these positions was replaced with a spin-labeled cysteine
residue, its ability to bind to its partner, the SpRI peptide,
was abolished, suggesting that these residues were at the
“binding side” of helix A′.
For the region consisting of residues 2060-2076, EPR
data clearly showed that residues at positions 2060-2070
exhibited periodicity for the ∆H0-1 values, with residues at
positions 2061, 2065, and 2068 exhibiting low values. Thus,
the region consisting of residues 2060-2070 was in a helical
conformation, with residues at positions 2061, 2065, and
2068 on the hydrophobic side of the helix. Again for
simplicity, we refer to this region as helix B′. Since we did
not scan the region between positions 2019 and 2059, our
results did not demonstrate whether there were two helices
in this region. We only demonstrated that both regions
(residues 2008-2018 and residues 2060-2070) were helical.
When each of the three residues at positions 2061, 2065,
and 2068 was replaced with a spin-labeled cysteine residue,
its ability to associate with SpRI was abolished, suggesting
that these residues were at the binding side of helix B′.
One of the interesting EPR results was that for the region
scanning residues 2071-2076. This region clearly did not
exhibit a periodicity in the ∆H0-1 values, and the values were
relatively large, indicating that these residues exhibited rather
flexible motions, suggesting a disordered conformation in
this region. Thus, this helical region ends around residue
2070 or 2071, in good agreement with our previous studies
(27). We prepared recombinant βI peptides of different
lengths, all starting at position 1898, but terminating at
position 2070, 2071, 2072, or 2073, and showed that the
peptide that terminates at position 2072 or 2073 associates
with SpRI-1-156. However, peptides that terminate at a
position prior to position 2072 do not associate with SpRI1-156, suggesting that the C-terminal segment of βI spectrin,
starting from residue 2073, is in a disordered conformation
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and is not critical to spectrin tetramer formation.
Our EPR data suggest that mutations of residues at the
hydrophobic face of a helix or helices (at positions 2011,
2014, 2018, 2061, 2065, and 2068) will be deleterious. The
known clinical mutations in the regions we studied are at
positions 2018 (50), 2019 (51), 2061 (52), and 2069 (53).
In summary, this work provides strong experimental
evidence that the region identified via sequence homology
as the partial domain in the C-terminus of βI spectrin consists
of helical regions, with the helix ending around residue 2070
and the region with residues 2071-2076 assuming a
disordered conformation. Furthermore, our results revealed
the amphipathic nature of the helical regions, with residues
2008, 2022, 2024, and 2018, and residues 2061, 2065, and
2068 at the hydrophobic side, and probably critical for RNβC association at the tetramerization site.
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